
In part one of our interview with Adam Friedman, M.D., FAAD, he discusses the data from a recent survey study that examines the influence of dermatologists' social media use on attracting new patients.

In part one of our interview with Adam Friedman, M.D., FAAD, he discusses the data from a recent survey study that examines the influence of dermatologists' social media use on attracting new patients.

From post-procedure laser to surgical facelift recovery, Dr. Joe Niamtu III offers insight and advice for patient healing challenges in and around the mid- and lower face from wearing a face mask.

In part two of our interview with Iltefat H. Hamzavi, M.D., he delves into the data from a recent article investigating the use ultraviolet germicidal irradiation (UVGI) as a method to disinfect N95 respirators for reuse during the COVID-19 pandemic.

In part one of our video interview with Iltefat H. Hamzavi, M.D., he discusses how ultraviolet germicidal irradiation is used in dermatology and how it can be used to disinfect N95 respirators to facilitate reuse during the COVID-19 pandemic.

Dr. Joe Niamtu offers pearls and pitfalls of the virtual cosmetic surgery consultation in telemedicine.

Dermatology patients are hungry for information that will ensure their safety during the COVID-19 pandemic, notes Vivian Shi, M.D. In this video, she discusses how to address patients' varying concerns in this uncertain time.

In the webinar, "Forging an Industry-Practice Partnership During COVID-19," Dr. Waldman and a panel of key executives discuss how the industry is adapting, the means by which we can support each other and what the future holds.

In the final installment of our interview with Amy Paller, M.D., she explains the similarities and differences between Kawasaki disease and the novel condition, multisystem inflammatory syndrome in children (MIS-C).

Part three of our interview with Amy Paller, M.D., focuses on the emergence of a multisystem inflammatory syndrome in children (MIS-C), what we know about this novel condition and its relationship to COVID-19.

In light of the ongoing pandemic, Vivian Shi, M.D., discusses potential risks dermatologists will want to keep in mind when evaluating patients currently taking immunomodulator or immunosuppressant drugs.

In part two of our interview with Amy Paller, M.D., she describes how she is staying informed about the latest COVID-19 research as it relates to the field, and shares some resources other dermatologists may find helpful during this crisis.

Amy Paller, M.D., discusses the pernio-like lesions associated with possible COVID-19 infection in younger individuals.


In this 1-hour webinar, Dr. Randolph Waldman and a panel of experts drill down into the legal concerns physicians are facing that are unique to the #COVID19 time period, including liability risk, consents, and protection strategies.

Jonathan Silverberg, M.D., Ph.D., MPH, discusses criteria to keep in mind when evaluating a patient with possible atopic dermatitis.

This week, we spoke with Mark Lebwohl, M.D., about his recent article featured in the Journal of the American Academy of Dermatology regarding biologic use in dermatology patients during the COVID-19 pandemic.

Dr. L. Mike Nayak recalls his decision to go virtual for his Medspa Mastery course. Adding #NoFilter to the name, he says that he wants to take the best part of going to conferences — small group and one-on-one discussions with colleagues — and bring it to the computer screen.

We brought physician and industry leaders together for a live webinar to examine new protocols being put in place in the private practice for once COVID-19 mandates are lifted. Our panel offered insights and answers on how to keep patients and staff safe when the appointments and surgeries are back on the schedule.

Dr. Mike Nayak talks issues of safety and practicality regarding national reopening guidelines, and the benefits of collaborating with local multi-specialty practices to share ideas and determine best practices together.

George Martin, M.D., dermatologist and program director for the Maui Derm meetings, has been working with the Maui Derm faculty, immunologists and members of industry to share emerging data regarding the novel coronavirus with the dermatology community. Listen to his insights in this video.


We brought physician and industry leaders together last week for a live webinar to examine the current state of the private practice as well as its viability over the next few months. Our panel offered insights and inspiration for remaining productive, proactive and positive as we work towards a return to business.

Dr. Randolph Waldman shares insights, realities and what’s yet to come for the private practice as a result of the Coronavirus crisis.

Jules Lipoff, M.D., dermatologist and assistant professor of clinical dermatology, Penn Medicine, discusses telemedicine in the era of COVID-19.

Catherine Maley offers valuable advice for building your prospective patient list by implementing a strategic virtual consultation plan.

Dr. Richard Gentile discusses his UltraLift technique, which uses ultrasound technology to dissect the layers of the face and neck for surgical lifting with less risk and better results.

Dr. Rania Agha demystifies plasma energy and shares her experience with nitrogen plasma.

Dr. Mark Mandell-Brown, President of AACS, details Day 3 from the Annual Scientific Meeting of the American Academy of Cosmetic Surgery. Highlights include complications from face- and neck-lifts and stem cell research.

Dr. Mike Nayak discusses the need for the internal neck anatomy to reflect the desired external result.

Dr. Angelo Cuzalina shares three face- and neck-lifting complications and solutions.